Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Profusa Inc (PFSA)

Profusa Inc (PFSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,414
  • Shares Outstanding, K 1,359
  • Annual Sales, $ 0 K
  • Annual Income, $ -8,710 K
  • EBIT $ -24 M
  • EBITDA $ -24 M
  • 60-Month Beta -0.14
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -167.67
  • Most Recent Earnings $-0.70 on 11/19/25
  • Next Earnings Date 03/04/26 [--]
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Information Systems

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8485 +15.14%
on 03/02/26
7.1250 -86.29%
on 02/03/26
-5.7055 (-85.38%)
since 02/02/26
3-Month
0.8485 +15.14%
on 03/02/26
15.1650 -93.56%
on 12/04/25
-12.1480 (-92.56%)
since 12/02/25

Most Recent Stories

More News
Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering

After Reevaluating its Near-term Capital Needs Given the Recent Changes in its Projected 2026 Revenue and Mayo Collaboration, the Company Determined that a $15 Million Offering is Not Required to Achieve...

PFSA : 0.9770 (-6.06%)
Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance

With strong underlying market demand, European distributor and expert physician customer purchase orders are being received by the Company as its 2026 revenue guidance range increases to $1.5 million -...

PFSA : 0.9770 (-6.06%)
Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies

Collaboration with Mayo Clinic aims to accelerate regulatory approval and commercialization of Lumee™ wearable continuous tissue oxygen monitoring product Seeking to develop and commercialize new...

PFSA : 0.9770 (-6.06%)
Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies

Collaboration with Mayo Clinic aims to accelerate regulatory approval and commercialization of Lumee™ wearable continuous tissue oxygen monitoring product Seeking to develop and commercialize new...

PFSA : 0.9770 (-6.06%)
Profusa Announces 1-for-75 Reverse Stock Split

BERKELEY, California, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering a next-generation technology...

PFSA : 0.9770 (-6.06%)
Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026

Study conducted at US sites evaluates Lumee TM in peripheral artery disease (PAD) patients BERKELEY, Calif, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”)...

PFSA : 0.9770 (-6.06%)
Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue

Research-use-only offerings are commercially available, enabling immediate product and service revenue generation Targets the global CRO market of $47.9 billion in 2025 and growing at 7% CAGR ...

PFSA : 0.9770 (-6.06%)
Profusa Adds Leading Greek Vascular Surgeon to Customer Base

Dr. Theodosios Bisdas is a renowned vascular surgeon and Head of Clinic of Vascular Surgery at the Athens Medical Center BERKELEY, Calif, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa”...

PFSA : 0.9770 (-6.06%)
Profusa Bolsters European Commercial Network with New French Distributor, MedSell

MedSell commercializes Lumee™ Oxygen tissue monitoring in France, building upon distributor partnerships in Spain, Germany, the Benelux countries, Austria, the United Kingdom, and Scandinavia, to now...

PFSA : 0.9770 (-6.06%)
Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35

New note provides greater repayment flexibility and less dilution with elimination of mandatory amortization payments, increased conversion floor price to $0.35, and expanded mandatory ELOC payments from...

PFSA : 0.9770 (-6.06%)

Business Summary

Profusa Inc. is a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual's biochemistry. Profusa Inc., formerly known as NorthView Acquisition Corp., is based in BERKELEY, Calif.

See More

Key Turning Points

3rd Resistance Point 1.1573
2nd Resistance Point 1.0699
1st Resistance Point 1.0234
Last Price 0.9770
1st Support Level 0.8895
2nd Support Level 0.8021
3rd Support Level 0.7556

See More

52-Week High 180.0000
Fibonacci 61.8% 111.5641
Fibonacci 50% 90.4242
Fibonacci 38.2% 69.2844
Last Price 0.9770
52-Week Low 0.8485

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar